Quick Answer
Co-Diagnostics, Inc. reported Shares Outstanding of 2.10 million shares for fiscal year 2025.
Co-Diagnostics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.10M | +6983336.7% |
| 2025 | 30 | -100.0% |
| 2024 | 1.10M | -96.5% |
| 2023 | 31.26M | +1.3% |
| 2022 | 30.87M | -8.7% |
| 2021 | 33.82M | +18.4% |
| 2020 | 28.56M | +64.7% |
| 2019 | 17.34M | +34.2% |
| 2018 | 12.92M | +4.9% |
| 2017 | 12.32M | +24.6% |
| 2016 | 9.88M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 48.14M | +50.8% | +33.1% |
| June 30, 2025 | 36.18M | +13.4% | +7.8% |
| March 31, 2025 | 33.57M | +7.3% | +1.6% |
| December 31, 2024 | 33.05M | +5.7% | +3.5% |
| September 30, 2024 | 31.93M | +4.1% | +0.1% |
| June 30, 2024 | 31.91M | +3.6% | +2.0% |
| March 31, 2024 | 31.28M | +2.1% | +0.1% |
| December 31, 2023 | 31.26M | +1.3% | +2.0% |
- Co-Diagnostics, Inc. showed an increase of +6983336.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2016–2025 period, Co-Diagnostics, Inc.’s shares outstanding has declined by 78.8% (from 9.88 million shares to 2.10 million shares).
- The most recent figure is from Co-Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: